VYNE icon

VYNE Therapeutics

106 hedge funds and large institutions have $160M invested in VYNE Therapeutics in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 11 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$28.1M
2 +$11.7M
3 +$10.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
5
BlackRock
BlackRock
New York
+$9.08M

Top Sellers

1 -$4.43M
2 -$3.92M
3 -$2.83M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.68M
5
O
OrbiMed
New York
-$2M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$667K
27
$657K
28
$614K
29
$535K
30
$520K
31
$495K
32
$467K
33
$446K
34
$411K
35
$367K
36
$333K
37
$278K
38
$258K
39
$248K
40
$219K
41
$218K
42
$200K
43
$179K
44
$178K
45
$177K
46
$169K
47
$166K
48
$164K
49
$161K
50
$152K